Literature DB >> 35810256

Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy.

Omer Jamy1, Sankalp Arora2, Ruby Meredith3, Donna Salzman4, Antonio Di Stasi4, Kentaro Minagawa5, Shin Mineishi5, Ayman Saad6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35810256     DOI： 10.1038/s41409-022-01757-9

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  5 in total

1.  Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation.

Authors:  E Granados; R de La Cámara; L Madero; M A Díaz; P Martín-Regueira; J L Steegmann; R Arranz; A Figuera; J M Fernández-Rañada
Journal:  Haematologica       Date:  2000-10       Impact factor: 9.941

2.  Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation.

Authors:  Anna Czyz; Myriam Labopin; Sebastian Giebel; Gerard Socié; Jane Apperley; Liisa Volin; Péter Reményi; Ibrahim Yakoub-Agha; Kim Orchard; Mauricette Michallet; Gernot Stuhler; Sridhar Chaganti; Martin Murray; Mahmoud Aljurf; Adrian Bloor; Jacob Passweg; Jürgen Finke; Mohamad Mohty; Arnon Nagler
Journal:  Am J Hematol       Date:  2018-03-30       Impact factor: 10.047

3.  Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant.

Authors:  Celalettin Eroglu; Cigdem Pala; Leylagül Kaynar; Kadir Yaray; M Tarkan Aksozen; Mehmet Bankir; Gökmen Zararsız; Okan Orhan; Mete Gündog; Oguz G Yıldız; Bülent Eser; Mustafa Cetin; Ali Unal
Journal:  Leuk Lymphoma       Date:  2013-03-27

Review 4.  Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.

Authors:  Boglarka Gyurkocza; Brenda M Sandmaier
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

5.  Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.

Authors:  V Bachanova; D I Marks; M-J Zhang; H Wang; M de Lima; M D Aljurf; M Arellano; A S Artz; U Bacher; J-Y Cahn; Y-B Chen; E A Copelan; W R Drobyski; R P Gale; J P Greer; V Gupta; G A Hale; P Kebriaei; H M Lazarus; I D Lewis; V A Lewis; J L Liesveld; M R Litzow; A W Loren; A M Miller; M Norkin; B Oran; J Pidala; J M Rowe; B N Savani; W Saber; R Vij; E K Waller; P H Wiernik; D J Weisdorf
Journal:  Leukemia       Date:  2013-08-30       Impact factor: 11.528
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.